Yield10 Bioscience
YTEN
#10581
Rank
A$0.49 M
Marketcap
A$0.48
Share price
0.00%
Change (1 day)
-83.20%
Change (1 year)
Categories

Earnings for Yield10 Bioscience (YTEN)

Earnings in 2024 (TTM): -A$19.23 Million

According to Yield10 Bioscience's latest financial reports the company's current earnings are A$0.81 Million. In 2023 the company made an earning of -A$20.57 Million a decrease over its 2022 earnings that were of -A$19.09 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Yield10 Bioscience from 2004 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$19.23 Million-6.53%
2023 -A$20.57 Million7.79%
2022 -A$19.09 Million21.96%
2021 -A$15.65 Million8.33%
2020 -A$14.45 Million-23.16%
2019 -A$18.8 Million43.85%
2018 -A$13.07 Million-2.27%
2017 -A$13.37 Million-8.65%
2016 -A$14.64 Million-50.87%
2015 -A$29.8 Million-21.78%
2014 -A$38.09 Million-10.01%
2013 -A$42.33 Million-919.48%
2012 A$5.16 M-109.35%
2011 -A$55.24 Million-0.31%
2010 -A$55.41 Million0.54%
2009 -A$55.11 Million-0.42%
2008 -A$55.34 Million15.01%
2007 -A$48.12 Million92.96%
2006 -A$24.94 Million149.46%
2005 -A$10 Million40.49%
2004 -A$7.12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-A$3.08 Million-82.99% Bahamas
NRC Health
NRC
A$39.23 M-317.08%๐Ÿ‡บ๐Ÿ‡ธ USA